Liu Yulin, Wang Chao, Wang Qi, Zhang Qing, Ning Songhao, Zhang Quanai
The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Integr Med Res. 2024 Dec;13(4):101088. doi: 10.1016/j.imr.2024.101088. Epub 2024 Sep 20.
Several systematic reviews (SRs) and meta-analyses (MAs) have explored the effectiveness and safety of acupuncture for Carpal Tunnel Syndrome (CTS), but findings are inconsistent and vary in quality. Therefore, this overview aims to evaluate these SRs and MAs critically, synthesizing existing evidence on acupuncture in treating CTS.
We searched 7 databases from their inception to April 25, 2024, using the keywords "acupuncture", "carpal tunnel syndrome", and "systematic review". Methodology and reporting quality were assessed using AMSTAR 2 and PRISMA. The risk of bias was evaluated using ROBIS, and evidence certainty was appraised using GRADE.
9 related SRs/MAs were included, with 8 judged as critically low quality and 1 rated as low quality by AMSTAR 2. According to the PRISMA checklist, while 7 SR/MAs were found to adequately report over 70 %, none reported all items. The ROBIS assessment rated 4 SRs/MAs with a low risk of bias and 5 with a high risk. The quality of evidence evaluated by GRADE was low or very low. Descriptive analyses indicated that acupuncture could effectively reduce pain intensity, but evidence on responder rate, symptom severity, functional status, and electrophysiological parameters was inconsistent. No serious adverse events associated with acupuncture were found.
Acupuncture might be beneficial for CTS. However, given the existing evidence limitations, the efficacy of acupuncture for CTS requires confirmation through further high-quality research.
PROSPERO (CRD42023409659).
多项系统评价(SR)和荟萃分析(MA)探讨了针灸治疗腕管综合征(CTS)的有效性和安全性,但结果不一致且质量参差不齐。因此,本综述旨在对这些SR和MA进行批判性评估,综合现有关于针灸治疗CTS的证据。
我们检索了7个数据库,检索时间从建库至2024年4月25日,关键词为“针灸”“腕管综合征”和“系统评价”。使用AMSTAR 2和PRISMA评估方法学和报告质量。使用ROBIS评估偏倚风险,使用GRADE评估证据确定性。
纳入9项相关SR/MA,其中8项被AMSTAR 2判定为极低质量,1项被评为低质量。根据PRISMA清单,虽然7项SR/MA被发现充分报告了70%以上的内容,但没有一项报告了所有项目。ROBIS评估将4项SR/MA评为低偏倚风险,5项评为高偏倚风险。GRADE评估的证据质量为低或极低。描述性分析表明,针灸可有效减轻疼痛强度,但关于缓解率、症状严重程度、功能状态和电生理参数的证据不一致。未发现与针灸相关的严重不良事件。
针灸可能对CTS有益。然而,鉴于现有证据的局限性,针灸治疗CTS的疗效需要通过进一步的高质量研究来证实。
PROSPERO(CRD42023409659)